发明名称 |
ANTI-PD1 ANTIBODIES, ACTIVATABLE ANTI-PD1 ANTIBODIES, AND METHODS OF USE THEREOF |
摘要 |
The invention relates generally to antibodies that specifically bind programmed cell death protein 1 (PD-1), activatable antibodies that specifically bind to PD-1 and methods of making and using these anti-PD-1 antibodies and anti-PD-1 activatable antibodies in a variety of therapeutic, diagnostic and prophylactic indications. |
申请公布号 |
US2017044259(A1) |
申请公布日期 |
2017.02.16 |
申请号 |
US201615209385 |
申请日期 |
2016.07.13 |
申请人 |
CytomX Therapeutics, Inc. |
发明人 |
Tipton Kimberly Ann;West James William;Chan Chanty Mariategue |
分类号 |
C07K16/28;C07K16/30;A61K39/395;A61K47/48 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
1. An isolated antibody or antigen binding fragment thereof (AB) that specifically binds to mammalian PD-1, wherein the AB has one or more of the characteristics selected from the group consisting of:
(a) the AB inhibits binding of mammalian PD-1 to mammalian PDL1 with an EC50 value less than 5 nM; (b) the AB inhibits binding of mammalian PD-1 to mammalian PDL2 with an EC50 value less than 5 nM; and (c) the AB specifically binds to human PD-1 and cynomolgus monkey PD-1. |
地址 |
South San Francisco CA US |